ATC

What side effects could occur with TECELRA?

Possible serious side effects that may occur with TECELRA

Since TECELRA is a different kind of treatment, the side effects you may experience could be different from those you have previously experienced with other treatments. Prior to infusion, your doctor will counsel you on all possible risks associated with TECELRA. Be sure to speak with your doctor or care team about any side effects you may experience.

Important Warning

  • You will likely be in a hospital before and after getting TECELRA
  • TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash
  • Tell all your healthcare providers that you were treated with TECELRA
  • After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 4 weeks
  • Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 4 weeks after you get TECELRA

One serious side effect that is possible with TECELRA is called cytokine release syndrome

What is CRS?

TECELRA can cause cytokine release syndrome, or CRS, which can be severe or life-threatening. This is when immune cells create a large and rapid release of cytokines, proteins that affect the immune system, into the blood. CRS can happen after treatment with some cancer therapies, including TECELRA.

You should be monitored for CRS at a healthcare facility daily for at least 7 days after treatment with TECELRA and remain within proximity of a healthcare facility for at least 4 weeks after treatment with TECELRA.

What does having CRS feel like?

The most common symptoms of CRS include fever, fast or irregular heartbeat, low blood pressure, nausea/vomiting, and headache. Tell your doctor or care team right away if you develop fever or any of these other symptoms after receiving TECELRA.

How long did CRS last in the TECELRA study?

In the TECELRA clinical study, half of CRS cases occurred within 2 days of treatment (range: 1-5 days) and half improved within 3 days (range: 1-14 days).

The most common side effects of TECELRA include:

  • Nausea
  • Vomiting
  • Fatigue
  • Infection
  • Constipation
  • Fever (100.4°F/38°C or higher)
  • Abdominal pain
  • Difficulty breathing
  • Decreased appetite
  • Diarrhea
  • Low blood pressure
  • Back pain
  • Fast heart rate
  • Chest pain
  • General body swelling
  • Low white blood cells
  • Low red blood cells
  • Low platelets
You are encouraged to report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch or to Adaptimmune at 1-855-24MYADAP (1-855-246-9232).
CRS=cytokine release syndrome.

want to learn more?

Explore the TECELRA
treatment journey arrow icon See the TECELRA study data arrow icon Discover resources and info about TECELRA arrow icon

INDICATION and IMPORTANT SAFETY INFORMATION

What is TECELRA?

TECELRA is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you. TECELRA is approved based on patient response data. Additional data are needed to confirm the clinical benefit of TECELRA. It is not known if TECELRA is safe and effective in children.

Please see Medication Guide, including Important Warning.

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.

After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 4 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 4 weeks after you get TECELRA. Your healthcare provider will do blood tests to follow your progress. It is important that you have your blood tested. If you miss a scheduled appointment for your collection of blood, call your healthcare provider as soon as possible to reschedule.

Before you receive TECELRA, tell your healthcare provider about all the medicines and supplements you take and your medical conditions, including: seizure, stroke, confusion, or memory loss; heart, liver, or kidney problems; low blood pressure; lung or breathing problems; recent or active infection; past infections that can be reactivated following treatment with TECELRA; low blood counts; pregnancy, you think you may be pregnant, or plan to become pregnant; breastfeeding; or taking a blood thinner.

The most common side effects of TECELRA include nausea, vomiting, fatigue, infection, constipation, fever (100.4°F/38°C or higher), abdominal pain, difficulty breathing, decreased appetite, diarrhea, low blood pressure, back pain, fast heart rate, chest pain, general body swelling, low white blood cells, low red blood cells, and low platelets.

You are encouraged to report side effects to the FDA at (800) FDA‑1088 or www.fda.gov/medwatch or to Adaptimmune at 1‑855‑24MYADAP (1-855‑246‑9232).

Please see Medication Guide, including Important Warning.

INDICATION and IMPORTANT SAFETY INFORMATION

What is TECELRA?

TECELRA is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you. TECELRA is approved based on patient response data. Additional data are needed to confirm the clinical benefit of TECELRA. It is not known if TECELRA is safe and effective in children.

Please see Medication Guide, including Important Warning.

IMPORTANT SAFETY INFORMATION

Important Warning: You will likely be in a hospital before and after getting TECELRA. TECELRA may cause side effects that can be severe or life-threatening. Call your healthcare provider or get emergency help right away if you get any of the following: fever (100.4°F/38°C or higher); chills/shivering; difficulty breathing; fast or irregular heartbeat; low blood pressure; fatigue; severe nausea, vomiting, or diarrhea; severe headache; or new skin rash. Tell all your healthcare providers that you were treated with TECELRA.

After getting TECELRA, you will be monitored daily at the healthcare facility for at least 7 days after the infusion. You should plan to stay close to a healthcare facility for at least 4 weeks. Do not drive, operate heavy machinery, or do other activities that could be dangerous for at least 4 weeks after you get TECELRA. Your healthcare provider will do blood tests to follow your progress. It is important that you have your blood tested. If you miss a scheduled appointment for your collection of blood, call your healthcare provider as soon as possible to reschedule.

Before you receive TECELRA, tell your healthcare provider about all the medicines and supplements you take and your medical conditions, including: seizure, stroke, confusion, or memory loss; heart, liver, or kidney problems; low blood pressure; lung or breathing problems; recent or active infection; past infections that can be reactivated following treatment with TECELRA; low blood counts; pregnancy, you think you may be pregnant, or plan to become pregnant; breastfeeding; or taking a blood thinner.

The most common side effects of TECELRA include nausea, vomiting, fatigue, infection, constipation, fever (100.4°F/38°C or higher), abdominal pain, difficulty breathing, decreased appetite, diarrhea, low blood pressure, back pain, fast heart rate, chest pain, general body swelling, low white blood cells, low red blood cells, and low platelets.

You are encouraged to report side effects to the FDA at (800) FDA‑1088 or www.fda.gov/medwatch or to Adaptimmune at 1‑855‑24MYADAP (1-855‑246‑9232).

Please see Medication Guide, including Important Warning.

You are now leaving this site

This link will take you to a third-party site that is not owned by Adaptimmune. Click “OK” if you would like to proceed or click “Cancel” to stay on this site.

OK
Cancel